ClinicalTrials.gg
Biological

mRNA-1345 respiratory syncytial virus vaccine clinical trials

Also written mRNA-1345.

Its developmentBy Moderna, step by step11 company-led studies, furthest phase 3: when each phase was reached, its deals, target and what is ahead.
studies test it
11
open now
0
in phase 3
5
first study started
2020

How each study uses mRNA-1345 respiratory syncytial virus vaccine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

mRNA-1345
11

Studies by the year they started

11 studies that test it; most in 2023 (5)

Studies that test mRNA-1345 respiratory syncytial virus vaccine, by start year
YearStudies
20201
20211
20223
20235
20251

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
3
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 0

ModernaTX, Inc. (11)

Often tested with

Tested in the same studies.

mRNA-1010 influenza vaccine (2) · mRNA-1273.214 COVID-19 vaccine (2) · MRNA-1365 (1) · 2019-nCoV Vaccine mRNA-1273 (1) · mRNA-1647 cytomegalovirus vaccine (1) · MRNA-1045 (1) · MRNA-1230 (1)

Studies

Open first, then newest update. How each study uses mRNA-1345 respiratory syncytial virus vaccine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Given beside what is tested · 1 — mRNA-1345 respiratory syncytial virus vaccine is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with mRNA-1345 respiratory syncytial virus vaccine

Codes

What other systems call mRNA-1345 respiratory syncytial virus vaccine · ClinicalTrials.gg INT001888

  • MeSH (NLM) C000722749mRNA-1345 respiratory syncytial virus vaccineOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.